founder

Joseph R. Osborne, M.D., Ph.D. is a distinguished expert in molecular imaging and radiology, currently serving as Chief of the Molecular Imaging & Therapeutics Service and Professor of Radiology at Weill Cornell Medical College. With an educational foundation that includes a Ph.D. in Cellular and Molecular Biophysics and an M.D. from Columbia University, Osborne has cultivated a profound impact on cancer imaging and therapy.

His research career began under the mentorship of Nobel Laureate Richard Axel, where he developed a strong focus on molecular imaging probes and theranostics, specifically prostate-specific membrane antigen (PSMA) imaging, used in the diagnosis and treatment of prostate cancer.

Dr. Osborne has held various key leadership roles, including his time at Memorial Sloan Kettering Cancer Center as Associate Vice Chairman of Research in Radiology and the Director of Molecular Imaging and Therapy Residency/Fellowship programs. His leadership extends to promoting health equity in radiology, exemplified by his role as Director of the Rad Health Equity Laboratory, where his research addresses both the development of cost-effective diagnostics and addressing healthcare disparities in imaging.

Dr. Osborne’s extensive publication record includes over 80 peer-reviewed papers, contributing significantly to advances in prostate cancer imaging, personalized medicine, and the role of genomic markers in radiological practices. He has led groundbreaking clinical trials focused on novel theranostic approaches to cancer treatment and imaging, which have opened new pathways for integrating diagnostics and therapy in oncology.

His research initiatives have received substantial funding from prominent institutions, including the National Institutes of Health (NIH) and the Department of Defense, further cementing his position as a leading figure in nuclear medicine and molecular imaging.

In addition to his academic and research accomplishments, Osborne has been actively involved in national committees such as the American Thyroid Association’s task force and the FDA’s Medical Imaging Drugs Advisory Committee, contributing to policy shaping and the advancement of diagnostic radiopharmaceuticals.

Dr. Osborne’s career reflects a commitment to innovation, interdisciplinary collaboration, and the pursuit of equity in healthcare, particularly in access to advanced imaging technologies .

Recommended

Manny Paris is a highly accomplished healthcare executive with over 25 years of experience in radiology and healthcare administration. He currently serves as the Director of Radiology Healthcare Administration at the University of Florida College of Medicine in Jacksonville. His extensive expertise includes health equity, molecular imaging, theranostics, strategic planning, program development, and operations management.

Manny’s career is marked by his leadership in radiology services in several prestigious healthcare institutions. At Memorial Sloan Kettering, he managed one of the nation’s leading Molecular Imaging and Therapeutics Services. There, he collaborated with global experts to spearhead innovations in nuclear medicine, PET/CT, and theranostics. He later served as the Director of Diagnostic Imaging and Interventional Radiology at New York Presbyterian-HVH, where he played a pivotal role in enhancing the institution’s cancer care services, acting as interim Director of the Cancer Center on two occasions, and as an Administrator on-call during the Covid period.

In addition to his work in healthcare management, Manny co-founded Rad Health Equity, a consulting firm dedicated to improving access to high-quality diagnostic and interventional services in underserved communities. His work in this field is recognized through his involvement in groundbreaking research on health disparities and access to cancer care.

Manny holds a Master’s degree in History from Rutgers University, a B.S. in Biology, a B.A. in History from William Paterson University, and a Nuclear Medicine Technology degree from the University of Medicine & Dentistry of New Jersey. Throughout his career, Manny has been a leader in expanding access to advanced diagnostic imaging technologies, continuously advocating for equitable care.

His contributions to healthcare research are notable, with published papers addressing disparities in access to cancer care, patient satisfaction across diverse cultural and linguistic backgrounds, and innovative approaches to integrating molecular imaging into oncology services.

Manny Paris’ career reflects a deep commitment to improving healthcare services and outcomes for all patients, particularly those in underserved communities. His passion for innovation and strategic leadership continues to drive meaningful change in the healthcare sector.

Recommended